Scientists
Researchers at the University of Wisconsin have made a breakthrough in cancer therapy by identifying four novel compounds that induce cellular senescence, a growth-arrested phenotype in cancer cells. This method, presented in the Journal of Biomolecular Screening, uses a high-throughput screening technique to identify compounds that induce senescence in prostate
Scientists
Scientists at the University of Tehran have made a significant discovery in understanding the effects of sildenafil on diabetes-induced cardiac cell apoptosis. Their study, published in the Canadian Journal of Physiology and Pharmacology, reveals that sildenafil treatment in diabetic mice reduces cardiac cell apoptosis, which is a major contributor to
Scientists
Recent research published in the Journal of Thoracic Oncology has demonstrated that induction chemotherapy before concurrent chemoradiotherapy has no significant benefit in improving survival rates for patients with unresectable Stage III non-small cell lung cancer. The study, conducted by Stinchcombe and colleagues, evaluated the effectiveness of induction chemotherapy in two
Scientists
Researchers at the University of Nebraska have developed a new immunohistochemical algorithm that can accurately classify diffuse large B-cell lymphoma (DLBCL) into its molecular subtypes. The new algorithm, which uses five specific antibodies, has a 93% concordance rate with gene expression profiling (GEP) classification, outperforming the previous algorithm developed by
Scientists
Researchers in the Netherlands conducted a phase I dose escalation study to evaluate the safety and tolerability of telatinib, a tyrosine kinase inhibitor that targets vascular endothelial growth factor receptor (VEGFR) -2, VEGFR-3, platelet-derived growth factor receptor-beta, and c-Kit. The study involved 53 patients with solid tumors who were refractory
Scientists
Scientists in the United States have made significant findings in their study on the role of protein phosphatase 5 (PP5) in protecting neurons against amyloid-beta toxicity in Alzheimer's disease. According to E. Sanchez-Ortiz and colleagues from Purdue University, PP5 plays a crucial role in inactivating mitogen-activated protein kinase
Scientists
A recent study published in the journal Molecular Cancer Research has identified a novel tumor-homing peptide that specifically binds to proteolytically processed collagen IV, accumulates in tumors, and blocks angiogenesis. The peptide, known as TLTYTWS, was generated through a combined in vivo and in vitro phage display screen using a
Scientists
Recent research from Shenzhen, People's Republic of China has investigated the role of endoplasmic reticulum stress and apoptosis in experimental diabetic nephropathy. The study, conducted by H.L. Sun and colleagues from Guangzhou University, aimed to assess the effects of ACE inhibitor on endoplasmic reticulum stress and apoptosis
Scientists
Recent research from Kaohsiung, Taiwan, has made a significant breakthrough in the detection of circulating tumor cells (CTCs) with KRAS oncogene mutations in patients with metastatic colorectal cancer. A study involving 76 patients treated with cetuximab plus chemotherapy found that the detection sensitivity, specificity, and accuracy of membrane-arrays for CTCs
Scientists
Researchers at the University of Texas have identified a crucial role of microRNAs in controlling the epithelial-to-mesenchymal transition (EMT) process in bladder cancer cells, which contributes to resistance to epidermal growth factor receptor (EGFR)-directed therapy. The study, published in Clinical Cancer Research, found that miRNA array screening and real-time
Scientists
The Centers for Disease Control and Prevention, in collaboration with other federal agencies, conducted a conference call on September 21, 2009, to discuss the clinical trials of flu vaccines in children. Rear Admiral Anne Schuchat, Director of the National Center for Immunization and Respiratory Diseases, and Anthony Fauci, Director of
Scientists
Rear Admiral Anne Schuchat, Director of the National Center for Immunization and Respiratory Diseases at the Centers for Disease Control and Prevention, reported encouraging results from clinical trials of a 2009 H1N1 influenza vaccine in healthy children. The trial, conducted in children from 6 months to 17 years of age,
